Список литературы

1. Агибалова Т.В., Альтшулер В.Б., Винникова М.А., Козырева А.В., Кравченко С.Л., Ненастьева А.Ю., Уткин С.И., Клинические рекомендации по диагностике и лечению абстинентного состояния с делирием, вызванного употреблением психоактивных веществ. - 2014., 26 с.

2. Руководство по наркологии. Под редакцией Н.Н. Иванца. - М.: Медпрактика - 2002, Т. 1, С. 233.

3. Уткин С.И. Неотложная наркология /Наркология: национальное руководство, под редакцией Н.Н. Иванца, И.П. Анохиной, М.А. Винниковой// - 2-е изд., перераб. и доп. - М.: ГЭОТАР-Медиа, 2016. - С. 585 - 587.

4. Allgaier C. Ethanol sensitivity of NMDA receptors. Neurochem Int. - 2002 Dec; 41(6) - 377 - 382.

5. Schmidt, K.J., Doshi M.R., Holzhausen J.M., Natavio A., Cadiz M., Winegardner J.E. Treatment of Severe Alcohol Withdrawal. Ann Pharmacother. 2016 May; 50(5): 389 - 401. doi: 10.1177/1060028016629161. Epub 2016 Feb 9.

6. Kattimani S., Bharadwaj B. Clinical management of alcohol withdrawal: A systematic review. Ind. Psychiatry J. 2013 Jul - Dec; 22(2): 100 - 108. doi: 10.4103/0972-6748.132914

7. Анохина И.П., Шамакина И.Ю. Фундаментальные механизмы зависимости от психоактивных веществ/Наркология: национальное руководство/ под ред. Н.Н. Иванца, И.П. Анохиной, М.А. Винниковой. - 2-е изд., перераб. и доп. - М.: ГЭОТАР-Медиа, 2016. - С. 96 - 116.

8. Victor M, Adams R.D., Collins G.H. The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition. 2nd ed. Philadelphia, PA: FA Davis; 1989.

9. Butterworth R.F., Kril J.J., Harpe C.G.R. Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcohol Clin Exp Res. 1993; 17: 1084 - 1088.

10. Donnino, M.W., Vega J., Miller J., Walsh M. Myths and misconceptions of Wernicke"s encephalopathy: what every emergency physician should know. Ann Emerg Med. 2007 Dec; 50(6): 715 - 21

11. Zuccoli G, Siddiqui N, Cravo I, et al. Neuroimaging findings in alcohol-related encephalopathies. Am J Roentgenol 2010; 195(6): 1378 - 1384.

12. Fernandes L.M.P., Bezerra F.R., Monteiro M.C., Silva M.L., de Oliveira F.R., Lima R.R., E.A., Maia C.S.F. Thiamine deficiency, oxidative metabolic pathways and ethanol-induced neurotoxicity: how poor nutrition contributes to the alcoholic syndrome, as Marchiafava-Bignami disease. European Journal of Clinical Nutrition advance online publication, 22 February 2017; doi:10.1038/ejcn.2016.267

13. Rogawski M.A. Update on the Neurobiology of Alcohol Withdrawal Seizures. Epilepsy Currents. 2005; 5(6): 225 - 230. doi:10.1111/j.1535-7511.2005.00071.x.

14. Karila L., Zarmdini R., Lejoyeux M. Delirium tremens//Rev Prat. - 2014. - N 10. - P. 1349 - 52. URL: https://www.ncbi.nlm.nih.gov/pubmed/25668827

15. Основные показатели деятельности наркологической службы в Российской Федерации в 2015 - 2016 годах. Статистический сборник. - М., 2017. С. 84.

16. Butterworth R.F., Gaudreau C., Vincelette J., Bourgault A.M., Lamothe F., Nutini A.M. Thiamine deficiency and Wernicke's encephalopathy in AIDS. Metab Brain Dis 1991; 6: 207 - 12;

17. Harper C.G., Giles M., Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J. Neurol. Neurosurg Psychiatry 1986; 49: 341 - 45

18. Альтшулер В.Б. Алкоголизм. - М.: ГЭОТАР-Медиа, 2010. - 264 с.

19. Слуцкин Э.В. Клиника и лечение атипичных форм алкогольного делирия. Автореферат дис. ... канд. мед. наук. Москва, 2005

20. Наркология: национальное руководство, под редакцией Н.Н. Иванца, И.П. Анохиной, М.А. Винниковой//ГЭОТАР-Медиа, 2016. - 944 с.

21. Stagno D., Gibson C., Breitbart W. The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care. 2004 Jun; 2(2): 171 - 9.

22. Diagnostic and Statistical Manual of Mental Disorders 5th ed.; DSM-5; American Psychiatric Association, 2013. - С. 598

23. Sanford A.M., Flaherty J.H. Do nutrients play a role in delirium? Curr Opin Clin Nutr Metab Care. 2014 Jan; 17(1): 45 - 50. doi: 10.1097/MCO.0000000000000022

24. Galvin R., Brathen G., Ivashynka A., Hillbom M. et al. EFNS Guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur. J. Neurol. 2010; 17: 1408 - 1418.

25. Thomson A.D., Guerrini I, Marshall E.J. The evolution and treatment of Korsakoff"s syndrome: out of sight, out of mind? //Neuropsychol Rev. 2012 Jun; 22(2): 81 - 92. doi: 10.1007/s11065-012-9196-z. URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545191/

26. Tekwani Parmanand H. Marchiafava-Bignami disease in chronic alcoholic patient//Radiol Case Rep. 2016 Sep; 11(3): 234 - 237. doi: 10.1016/j.radcr.2016.05.015

27. Алкоголизм: Руководство для врачей / Под ред. Н.Н. Иванца, М.А. Винниковой. - М.: ООО "Издательство "Медицинское информационное агентство", 2011. 856 с.

28. Wenz H., Eisele P., Artemis D., Forster A., Brockmann M.A. Acute Marchiafava-Bignami Disease with Extensive Diffusion Restriction and Early Recovery: Case Report and Review of the Literature J Neuroimaging. 2014 Jul - Aug; 24(4): 421 - 4. doi: 10.1111/j.1552-6569.2012.00755

29. Дамулин И.В., Струценко А.А. Болезнь (синдром) Маркиафавы-Биньями. Российский медицинский журнал. 2016; 22(6): 332 - 336. DOI http://dx.doi.org/10.18821/0869-2106-2016-22-6-332-336.

30. Hillbom M., Saloheimo P., Fujioka S., Wszolek Z.K, Juvela S., Leone M.A. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases J. Neurol. Neurosurg. Psychiatry. 2014 Feb; 85(2): 168 - 173. doi: 10.1136/jnnp-2013-305979

31. Ghio L., Cervetti A., Respino M., Belvederi Murri M., Amore M. Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review. J Psychiatr. Pract. 2014; Jul; 20(4): 294 - 300. doi: 10.1097/01.pra.0000452567.84825.07.

32. Sivilotti M.L., Burns M.J., Aaron C.K., Greenberg M.J. Pentobarbital for severe gamma-butyrolactone withdrawal. Annals of Emergency Medicine, 2001, 38: 660 - 665

33. Kamal R.M., van Noorden M.S., Wannet W., Beurmanjer H., Dijkstra B.A., Schellekens A. Pharmacological Treatment in (GHB) and-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs. 2017; Jan; 31(1): 51 - 64. doi: 10.1007/s40263-016-0402-z.

34. Tietz C., Strang C.M. The addicted patient in anaesthesia - benzodiazepine dependence. Anasthesiol Intensivmed Notfallmed Schmerzther. 2015; N 50(6): 426 - 33; quiz 434. doi: 10.1055/s-0041-102700

35. Das S., Sah D., Nandi S., Das P. Opioid Withdrawal Presenting as Delirium and Role of Buprenorphine: A Case Series. Indian J. Psychol. Med. 2017; Sep - Oct; 39(5): 665 - 667. doi: 10.4103/0253-7176.217027.

36. Horacek R., Krnacova B., Prasko J., Latalova K. Delirium as a complication of the surgical intensive care// Neuropsychiatr Dis Treat. 2016 Sep 22; 12: 2425 - 2434 URL: https://www.ncbi.nlm.nih.gov/pubmed/27703360

37. Rodrigo C., Seneviratne D., Sriram G., Jayasinghe S. Acute coronary ischemia during alcohol withdrawal: a case report//J Med Case Reports. 2011; 5: 369. doi: 10.1186/1752-1947-5-369

38. Cuculi F., Kobza R., Ehmann T., Erne P. ECG changes amongst patients with alcohol withdrawal seizures and delirium tremens.//Swiss Med Wkly. 2006 Apr 1; 136 (13 - 14): 223 - 7

39. Sand T., G., Michler R., et al. Clinical utility of EEG in alcohol-related seizures.// Acta Neurol Scand. - 2002. 105: 18 - 24

40. G., Ben-Menachem E., Brodtkorb E., et al. EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force.// Eur J Neurol. 2005; 12(8): 575 - 81

41. Sullivan E.V., Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff syndrome.// Alcohol Alcohol. - 2009. - N 44(2). - P. 155 - 65. doi: 10.1093/alcalc/agn103. Epub 2008 Dec 9.

42. Jung Y., Chanraud S., Sullivan E.V. Neuroimaging of Wernicke"s Encephalopathy and Korsakoff"s Syndrome// Neuropsychol Rev. - 2012 - N 22(2) P. 170 - 180. doi: 10.1007/s11065-012-9203-4

43. Schuckit M.A. Recognition and management of withdrawal delirium (delirium tremens)// N Engl J Med. 2014 Nov 27; 371(22): 2109 - 13. doi: 10.1056/NEJMra1407298

44. Long D. et al. The emergency medicine management of severe alcohol withdrawal// The American Journal of Emergency Medicine, vol. 35, no. 7, 2017, pp. 1005 - 1011., doi:10.1016/j.ajem.2017.02.002.

45. Sessler C.N., Gosnell M.S., Grap M.J., Brophy G.M., O'Neal P.V., Keane K.A., Tesoro E.P., Elswick R.K. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002; 166 (10): 1338 - 1344.

46. Meagher D., Maeve L. The active management of delirium: improving detection and treatment. Advances in Psychiatric Treatment (2008), vol. 14, 292 - 301 doi: 10.1192/apt.bp.107.003723

47. Han J.H., Vasilevskis E.E., Schnelle J.F., Shintani A., Dittus R.S., Wilson A., Ely E.W., The Diagnostic Performance of the Richmond Agitation Sedation Scale for Detecting Delirium in Older Emergency Department Patients//Acad Emerg Med. - 2015. - 22(7): 878 - 882. doi: 10.1111/acem.12706

48. Oldham M., Ivkovic A. Pellagrous encephalopathy presenting as alcohol withdrawal delirium: A case series and literature review//Addict Sci Clin Pract. 2012; 7(1): 12.

49. Дамулин И.В. 2005 Когнитивные расстройства при алкоголизме//РМЖ - 2005. - N 5. С. 785 URL:https://www.rmj.ru/articles/obshchie-stati/Kognitivnye_rasstroystva_pri_alkogolizme/

50. Brust J.C.M. Acute withdrawal: diagnosis and treatment/Handbook of Clinical Neurology. - 2014. - Vol. 125. - P. 123 - 131. doi: 10.1016/B978-0-444-62619-6.00008-2.

51. Trivedi M., Shelly M., Park G. Advances in patient comfort: awake, delirious, or restrained. British Journal of Anaesthesia 2009; 103(1): 2 - 5 doi:10.1093/bja/aep127

52. Sachdeva A., Choudhary M., Chandra M. Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond// J. Clin. Diagn. Res. - 2015 URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606320/pdf/jcdr-9-VE01.pdf

53. Mayo-Smith M.F., Beecher L.H., Fischer T.L., Gorelick D.A., Guillaume J.L., Hill A., Jara G., Kasser C., Melbourne J. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Working Group on the Management of Alcohol Withdrawal Delirium, Practice Guidelines Committee, American Society of Addiction Medicine. Arch Intern Med. 2004 Jul 12; 164(13): 1405 - 12.

54. Ntais C., Pakos E., Kyzas P., Ioannidis J.P. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2005 Jul 20; (3): CD005063. DOI:10.1002/14651858.CD005063.pub2

55. Amato L., Minozzi S., Vecchi S., Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010 Mar 17; (3): CD005063. doi: 10.1002/14651858.CD005063.pub3.

56. Sadock BJ, Sadock VA, Ruiz P, Kaplan HI. Kaplan & Sadock"s Comprehensive Textbook of Psychiatry. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2017. p. 1636.

57. Hoffman R.S., Weinhouse G.L. Management of moderate and severe alcohol withdrawal syndromes. - 2017. URL: https://www.uptodate.com/contents/management-of-moderate-and-severe-alcohol-withdrawal-syndromes?search=delirium%20tremens&source=search_result&selectedTitle=1~18&usage_type=default&display_rank=1#H16]

58. Иващенко Д.В., Брюн Е.А., Савченко Л.М., Сычев Д.А. Терапия неосложненного синдрома отмены алкоголя с позиций доказательной медицины: фокус на бензодиазепины//Наркология. - 2016. - N 12. - С. 83 - 91

59. Michael F. Weaver M.F. Prescription Sedative Misuse and Abuse//Yale J Biol Med. 2015 Sep; 88(3): 247 - 256

60. el-Guebaly N.A., Carra`G., Galanter M. Textbook of Addiction Treatment: International Perspectives//Springer Milan Heidelberg New York Dordrecht London/ - 2015. DOI 10.1007/978-88-470-5322-9

61. Robinson GM, Sellers EM, Janecek E. Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique Clin Pharmacol Ther. 1981 Jul; 30(1): 71 - 6.

62. Hammond D.A., Rowe J.M., Wong A., Wiley T.L., Lee K.C., Kane-Gil S.L. Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review //Hospital Pharmacy. - 2017, Vol. 52(9). - P. 607 - 616. DOI: 10.1177/0018578717720310

63. Gold J.A., MD, Rimal B., Nolan A., Nelson L.S. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens // Crit Care Med. Author manuscript; available in PMC 2012 Vol. 35, N 3; 724 - 730. doi: 10.1097/01.CCM.0000256841.28351.80

64. Jain R., Arun P., Sidana A., Sachdev A. Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium//Indian J Psychiatry. 2017 Oct - Dec; 59(4): 451 - 456. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806324/

65. Meagher D.J. Delirium: optimising management//BMJ. - 2001. Jan 20; 322(7279): 144 - 149. doi: 10.1136/bmj.322.7279.144

66. Остроумова О.Д. Удлинение интервала QT//"РМЖ" - 2001, N 18. - С. 750 URL: https://www.rmj.ru/articles/kardiologiya/Udlinenie_intervala_QT/#ixzz56VWfjsRs

67. Trzepacz P., William Breitbart W., Franklin J., Levenson J., Martini R., Wang P. Practice Guideline for the Treatment of Patients with Delirium. American psychiatric association steering committee on practice guidelines. American Psychiatric Association, 1999. URL: http://umh1946.edu.umh.es/wp-content/uploads/sites/172/2015/04/APA-Delirium.pdfH

68. Barrons R., Roberts N. The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome. J Clin Pharm Ther. 2010 Apr; 35(2): 153 - 67. doi: 10.1111/j.1365-2710.2009.01098.x.

69. Minozzi S., Amato L., Vecchi S., Davoli M. Anticonvulsants for alcohol withdrawal // Cochrane Database Syst Rev. 2010 Mar 17; (3): CD005064. doi: 10.1002/14651858.CD005064.pub3

70. Mariani J.J., Rosenthal R.N., Tross S., Singh P., Anand O.P. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. //Am J Addict. - 2006. - 15(1); 76 - 84.

71. Frank L.L., Thiamin in Clinical Practice. Journal of Parenteral and Enteral Nutrition 2015; 39 (5): 503 - 520.

72. Schneider P., Nejtek V.A., Hurd C.L., A case of mistaken identity: alcohol withdrawal, schizophrenia, or central pontine myelinolysis? //Neuropsychiatr Dis Treat. 2012; 8: 49 - 54. doi: 10.2147/NDT.S27634

73. Интенсивная терапия. Национальное руководство. Краткое издание / под ред. Б.Р. Гельфанда, И.Б. Заболотских. - 2-е изд., перераб. и доп. - М.: ГЭОТАР-Медиа, 2017. - 928 с.

74. Soupart A., Decaux G. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clin Nephrol. 1996 Sep; 46(3): 149 - 69. URL: https://www.ncbi.nlm.nih.gov/pubmed/8879850

75. Sarai M., Tejani A.M., Chan A.H., Kuo I.F., Li J. Magnesium for alcohol withdrawal. Cochrane Database Syst Rev. 2013 Jun 5; (6): CD008358. doi: 10.1002/14651858.CD008358.pub2.

76. Robakis T.K., Hirsch L.J. Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care. 2006; 4(1): 35 - 46

77. Nechifor M. Magnesium in addiction - a general view. Magnes Res. 2018 Aug 1; 31(3): 90 - 98. doi: 10.1684/mrh.2018.0443

78. Москвичев В.Г., Волохова Р.Ю., Зиновьева М.А. Лечение алкогольного делирия в стационаре Лечащий врач. - 2005. - N 06 URL: https://www.lvrach.ru/2005/06/4532699/